These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 12456382

  • 1. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ.
    Am J Respir Crit Care Med; 2003 May 01; 167(9):1232-8. PubMed ID: 12456382
    [Abstract] [Full Text] [Related]

  • 2. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun 01; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 3. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
    Currie GP, Bates CE, Lee DK, Jackson CM, Lipworth BJ.
    Eur J Clin Pharmacol; 2003 May 01; 59(1):11-5. PubMed ID: 12743669
    [Abstract] [Full Text] [Related]

  • 4. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
    Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul 27; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 8. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
    Fardon TC, Lee DK, Hodge MR, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2005 Sep 27; 95(3):259-65. PubMed ID: 16200817
    [Abstract] [Full Text] [Related]

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 27; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 10. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Feb 27; 88(2):227-35. PubMed ID: 11868930
    [Abstract] [Full Text] [Related]

  • 11. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW.
    Eur Respir J; 2009 Jun 27; 33(6):1302-8. PubMed ID: 19164343
    [Abstract] [Full Text] [Related]

  • 12. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan 27; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 13. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 27; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 14. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
    Camargo CA, Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH, Ortega HG, Ferro TJ.
    J Asthma; 2010 Feb 27; 47(1):76-82. PubMed ID: 20100025
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
    Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.
    Chest; 2001 Apr 27; 119(4):1021-6. PubMed ID: 11296164
    [Abstract] [Full Text] [Related]

  • 16. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
    Buchvald F, Bisgaard H.
    Ann Allergy Asthma Immunol; 2003 Sep 27; 91(3):309-13. PubMed ID: 14533665
    [Abstract] [Full Text] [Related]

  • 17. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.
    N Engl J Med; 1998 Jul 16; 339(3):147-52. PubMed ID: 9664090
    [Abstract] [Full Text] [Related]

  • 18. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
    J Allergy Clin Immunol; 2004 Feb 16; 113(2):245-51. PubMed ID: 14767437
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.